Azienda Ospedaliera San Gerardo di Monza

Monza, Monza E Brianza 20090

0 studies enrolling now · 5 studies all time

What they study most

Advanced Malignancies, Carcinoma, Colorectal Cancer, Idiopathic Pulmonary Fibrosis, Lung Cancer, Myeloid Leukemia, Chronic, Chronic Phase, Non-small Cell Lung Cancer, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Studies at this site

• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
• A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia — Running, not enrolling
• ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants — Completed
• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
• Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) — Stopped early